Weight loss drug pilot rollout ‘paused’ in England, says Obesity Health Alliance A report by the Obesity Health Alliance also revealed waiting lists for overweight and obesity management services were “routinely reaching three to five years”.…
More than 1.5 million people could be given tirzepatide for weight loss under NHS proposals Priority will be given to patients with the highest clinical need, identified as those with a BMI of more than 40 and at least three specific weight-related health problems.…
Prescribing dilemma: balancing risk and benefits of off-label migraine treatment in a child The second of a new series of articles exploring real-world dilemmas that pharmacist prescribers encounter in clinical practice.…
NICE rejects cabotegravir for PrEP in draft guidance Draft guidance said the HIV pre-exposure prophylaxis (PrEP) treatment cabotegravir is not recommended because “it is not possible to determine the cost-effectiveness estimate ... without further analyses from the manufacturer”.…
MHRA approves dupilumab for treatment of uncontrolled COPD The regulator has granted marketing authorisation for a subcutaneous injection as an add-on maintenance treatment for adults with uncontrolled COPD.…
NICE recommends emergency kits for people with adrenal insufficiency to cut hospital admissions The new guidance says healthcare providers should consider providing eligible patients with two or three emergency adrenal insufficiency kits.…
Alzheimer’s treatment lecanemab too costly for NHS, says NICE draft guidance The National Institute for Health and Care Excellence has determined that the small benefit that lecanemab provides patients in the early stages of Alzheimer’s disease does not justify the cost to the NHS.…
The unregulated semaglutide prescribing circus Why there should be stronger regulations around the prescribing of semaglutide, speaking from experience as a trainee pharmacist supplying this medicine from a community pharmacy in central London.…
Lessons from testing 2,300 patients at the UK’s first CYP2C19 genotyping system Specialist clinical pharmacist Alex Matos explains what his team has learned in the two years since setting up the NHS Tayside project to genotype acute stroke patients with an indication for clopidogrel.…
First gene-editing therapy recommended by NICE to treat people with beta thalassaemia NHS England said that around 460 patients aged 12 years and over could benefit from the treatment.…
